{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021732","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.038878+00:00","generated_at":"2026-06-01T07:40:43.448538+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pulmatrix cross-licenses iSPERSE with MannKind; transfers Bedford R&D facility to extend cash runway","bullets":["Pulmatrix grants MannKind exclusive iSPERSE licenses for clofazimine, NTM lung disease, insulin; non-exclusive for endocrine, ILD.","MannKind grants Pulmatrix exclusive Cricket device license for PUR3100 (DHE/migraine); non-exclusive for neurological disease.","MannKind assumes Pulmatrix's Bedford R&D facility lease and equipment; expected close July 2024.","CEO: transaction validates iSPERSE technology and extends cash runway into 2026.","MannKind to provide development services under MSA and may hire some Pulmatrix R&D staff."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021732","json":"https://secwatch.observer/filing/0001493152-24-021732.json","markdown":"https://secwatch.observer/filing/0001493152-24-021732.md","text":"https://secwatch.observer/filing/0001493152-24-021732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224021732/0001493152-24-021732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224021732/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:40:43.448538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}